ugichem's Unattributed VC - II Round

ugichem raised a round of funding on May 28, 2013.

ugichem is developing antisense drugs based on its proprietary Ugimer platform for unmet medical needs in immune-mediated inflammatory diseases (IMID). Ugimers overcome the shortcomings of standard a…

Articles about ugichem's Unattributed VC - II Round: